Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2025-07-14 AGM Information
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic ASA - Minutes of Extraordinary General Meeting - Attachment: Navamedic_ASA_Minutes_of_EGM_07_14_2025.pdf
AGM Information Classification · 99% confidence The document is titled "PROTOKOLL FRA EKSTRAORDINÆR GENERALFORSAMLING" / "MINUTES OF EXTRAORDINARY GENERAL MEETING". This explicitly identifies the document as the official record (minutes) of a shareholder meeting, specifically an Extraordinary General Meeting (EGM). While the content details resolutions regarding a share capital increase (Rights Issue), the primary nature and title of the document classify it as the formal record of the meeting where these decisions were made. This aligns best with the general category for shareholder meeting materials, which is AGM-R (AGM Information), as there is no specific code for EGM Minutes, and AGM-R often serves as the catch-all for formal shareholder meeting records, especially when voting results are mentioned (Appendix 2). It is not a general announcement (RPA/RNS) because it contains the full, detailed minutes, not just a notice of publication. It is also not DVA (Declaration of Voting Results) as it is the full protocol, not just the results summary.
2025-07-14 Norwegian
Navamedic ASA - Minutes of Extraordinary General Meeting
AGM Information Classification · 98% confidence The document is explicitly titled 'Minutes of Extraordinary General Meeting' and confirms that all agenda items were approved. This content directly relates to the proceedings and outcomes of a shareholder meeting. The closest matching category is 'AGM Information' (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Although this is an EGM (Extraordinary General Meeting), the nature of the document (minutes/results of a general meeting) aligns best with AGM-R compared to other options like DVA (Declaration of Voting Results), which is usually a summary of results rather than the full minutes, or RNS (Regulatory Filings), which is a fallback. Given the content is the official minutes of the meeting, AGM-R is the most appropriate classification.
2025-07-14 English
Navamedic ASA: Mandatory notice of trade - Attachment: Notification_of_trade_JD.pdf
Director's Dealing Classification · 100% confidence The document text is structured as a formal notification detailing a transaction involving shares by a person discharging managerial responsibilities (a Primary insider: Chairman of the Board). Specifically, it reports that Jostein Asbjørn Davidsen 'Bought shares' of Navamedic ASA on 11.7.2025. This content directly matches the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives.
2025-07-11 English
Navamedic ASA: Mandatory notice of trade
Director's Dealing Classification · 100% confidence The document is titled 'Navamedic ASA: Mandatory notice of trade' and explicitly states that a Primary Insider (Chairman of the Board) acquired shares. It references legal obligations under the Market Abuse Regulation (MAR) Article 19. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The code for this is DIRS.
2025-07-11 English
Navamedic ASA: Updated key information relating to the rights issue
Capital/Financing Update Classification · 98% confidence The document explicitly discusses an 'Updated key information relating to the rights issue' for Navamedic ASA. A rights issue is a method of raising capital by offering existing shareholders the right to purchase additional new shares. This directly corresponds to the definition of 'Capital/Financing Update' (CAP). Although it mentions a future prospectus and EGM approval, the core content is the announcement of the terms and schedule for the capital raising activity.
2025-07-10 English
Navamedic ASA - Additional underwriting commitments in the Rights Issue
Capital/Financing Update Classification · 98% confidence The document text is an announcement from Navamedic ASA regarding 'Additional underwriting commitments in the Rights Issue'. It discusses financing activities, specifically securing additional underwriting commitments for a proposed rights issue intended to partly finance an acquisition. This content directly relates to fundraising, financing activities, and capital structure changes. Based on the definitions, this aligns perfectly with the 'Capital/Financing Update' category (Code: CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it pertains to a specific corporate finance action.
2025-06-29 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.